Stock Market News

Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow

May 7, 2025 - 07:53
 0
Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow
Read More

Tags:

Previous Article

Standard Chartered predicts BNB will more than double in 2025

Next Article

Fair Isaac Co. (NYSE:FICO) Receives $2,277.46 Consensus Target Price from Analysts

Related Posts

Norway wealth fund posts $40 billion first-quarter loss on tech weakness

Norway wealth fund posts $40 billion first-quarter loss...

Apr 24, 2025  0

Newmont profit beats estimates as gold rally trumps weak output

Newmont profit beats estimates as gold rally trumps wea...

Apr 23, 2025  0

Lufthansa strikes upbeat tone, monitoring for U.S. demand weakness

Lufthansa strikes upbeat tone, monitoring for U.S. dema...

Apr 29, 2025  0